The Cartagena Dialogue was designed to strengthen the UNGASS 2016 process by identifying key ideas to review drug policies and by making steps to coordinate inter-regional efforts on the preparation, negotiation of the Outcome Document and on the UNGASS itself in April 2016.
This paper by the WHO Executive Board focuses on the critical public health elements of a comprehensive, balanced and inclusive drug policy; in the context of the UNGASS on the World Drug Problem.
This qualitative study aimed to examine patient motivations for, and perceptions and experiences of, OST in prisons in New South Wales (NSW), Australia.
The EMCDDA reviews the effectiveness of brief interventions in an emergency department setting, presenting an analysis of five systematic reviews and 16 randomised controlled trials.
This World Health Organisation handbook addresses the main issues of HIV-related point-of-care testing to help service-providers adhere to quality standards.
A specialist meeting on the relevance of the UNGASS 2016 on South East Europe produced a document that outlined recommendations and key points for the region.
Global data on licit opioid consumption shows very low levels in many countries, suggesting that pain control may be inadequate for a large number of patients worldwide.
The EMCDDA produced a new report compiling and analysing all the data available on the use of illicit drugs and new psychoactive substances in Europe in the year 2015.
